Ian Mortimer

Mr Mortimer has served as our President and Chief Executive Officer since June 2021 and as our interim Chief Financial Officer since June 2025. He has held several roles of increasing responsibility since joining Xenon in 2013 as our Chief Financial Officer, including President, Chief Operating Officer, and Corporate Secretary. Before Xenon, Mr Mortimer was the Executive Vice President and Chief Financial Officer at Tekmira Pharmaceuticals Corporation (now Arbutus Biopharma Corporation), where he managed the company’s finances and capital markets activities, including leading their Nasdaq listing in 2010. His earlier career included serving as Chief Financial Officer at Inex Pharmaceuticals, which he joined in 1997. Mr Mortimer also lends his expertise to the board of directors for BIOTECanada, as well as Perimeter Medical Imaging AI, Inc., a publicly traded medical device company focused on advanced medical imaging tools. He earned his MBA from Queen’s University, his BSc in microbiology from the University of British Columbia, and is a Chartered Professional Accountant and Certified Management Accountant.